Dexamethasone increases angiopoietin-1 and quiescent hematopoietic stem cells: a novel mechanism of dexamethasone-induced hematoprotection

FEBS Lett. 2008 Oct 15;582(23-24):3509-14. doi: 10.1016/j.febslet.2008.09.021. Epub 2008 Sep 18.

Abstract

Angiopoietin-1 (Ang-1) is known to have hematoprotective effects by increasing the quiescence of hematopoietic stem cells. However, it remains to be determined if the upregulation of Ang-1 and the subsequent increase in the quiescence of hematopoietic stem cells are also involved in the dexamethasone (Dex)-mediated bone marrow protection. Here Western blotting and flow cytometric analyses demonstrate that Dex increases the levels of Ang-1 in mouse bone marrow and the quiescence of hematopoietic stem cells. Our data for the first time suggest that the increased quiescence of hematopoietic stem cells provides a novel mechanism of Dex-induced hematoprotection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiopoietin-1 / biosynthesis*
  • Angiopoietin-1 / genetics
  • Animals
  • Base Sequence
  • Bone Marrow / drug effects
  • Bone Marrow / metabolism
  • Cytoprotection*
  • Dexamethasone / pharmacology*
  • Glucocorticoids / pharmacology*
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Myeloid Progenitor Cells / cytology
  • Myeloid Progenitor Cells / drug effects*
  • Myeloid Progenitor Cells / metabolism
  • RNA Stability / drug effects
  • RNA, Messenger / biosynthesis
  • Receptors, Glucocorticoid / biosynthesis
  • Receptors, Glucocorticoid / genetics
  • Response Elements

Substances

  • Angiopoietin-1
  • Glucocorticoids
  • RNA, Messenger
  • Receptors, Glucocorticoid
  • Dexamethasone